ALTANA Pharma AG (AAA) Receives Approval To Market Ciclesonide Nasal Spray In The U.S.
10/23/2006 12:33:12 PM
BAD HOMBURG & KONSTANZ, Germany--(BUSINESS WIRE)--ALTANA AG (NYSE:AAA)(FWB:ALT)(GER:ALT) announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for OMNARIS™ (Ciclesonide nasal spray), 200µ once-daily.
>>> Discuss This Story
comments powered by